Clinical Trials

NCT05576207 | COMPLETED | NA
3390 participants

BEP Supplementation Research in Bangladesh (JiVitA-BEP-IR)

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-02
Start Date:
2022-10-15
Completion:
2025-04-24
Conditions
  • Fetal Growth Retardation
  • Low Birth Weight
  • Preterm Birth
  • Gestational Weight Gain
  • Anemia of Pregnancy
  • Stunting
  • Pregnancy Complications
Interventions
  • DIETARY_SUPPLEMENT
No Results Yet
NCT05445843 | ACTIVE_NOT_RECRUITING | PHASE2
95 participants

Study of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1 Expression < 1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation.

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-02
Start Date:
2022-12-06
Completion:
2024-11-04
Conditions
  • Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation
Interventions
  • DRUG
NCT05359653 | RECRUITING | PHASE1/PHASE2
74 participants

Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-02
Start Date:
2023-08-01
Completion:
2027-06-01
Conditions
  • Multiple Sclerosis (MS)
  • Multiple Sclerosis, Relapsing-Remitting
  • Multiple Sclerosis, Primary Progressive
  • Multiple Sclerosis, Chronic Progressive
  • Multiple Sclerosis Relapse
  • Multiple Sclerosis Brain Lesion
  • Multiple Sclerosis Benign
Interventions
  • DRUG
No Results Yet
NCT05261633 | COMPLETED
17 participants

Diffusion MRI of the Abdomen

Study Type:
OBSERVATIONAL
Last Updated:
2026-07-02
Start Date:
2023-11-22
Completion:
2026-06-30
Conditions
  • Abdominal Imaging
Interventions
  • DEVICE
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page